^
    10ms
    RETRACTION: LncRNA CCAT2 Promotes the Proliferation and Metastasis of Colorectal Cancer Through Activation of the ERK and Wnt Signaling Pathways by Regulating GNB2 Expression. (PubMed, Cancer Med)
    17 (2024): e70169, https://doi.org/10.1002/cam4.70169...The authors further stated that, upon reviewing the published article, they discovered multiple issues related to image overlap and redundancy. All parties agree that the overlapping and duplicated images constitute a major error in the article and it must be retracted.
    Journal • PARP Biomarker
    |
    CCAT2 (Colon Cancer Associated Transcript 2)
    |
    E7016
    1year
    Study of Poly (ADP-Ribose) Polymerase (PARP) Inhibitor E7016 in Combination With Temozolomide in Subjects With Advanced Solid Tumors (clinicaltrials.gov)
    P1, N=12, Terminated, Eisai Inc. | Completed --> Terminated; Strategic decision, which is unrelated to safety
    Trial termination
    |
    temozolomide • E7016